America’s Gynecologists was founded by leading physicians who recognized the need for a centralized online resource for women’s health information. At a time when reliable medical content was fragmented, the organization set out to create a trusted national destination for patient education.

Howbridge helped develop the brand, content platform, physician engagement strategy, and digital presence that supported nationwide growth and awareness.

Rise On, a program within the Justice Resource Institute (JRI), set out to expand access to care for underserved communities through a modern, multilingual telehealth and support platform. They needed strategy, branding, technology, and funding support.

Howbridge helped develop the strategic plan, brand, telehealth platform, fundraising approach, and community engagement model.

ForCast Orthopedics was preparing to bring a proprietary orthopedic treatment platform out of stealth and into investor and clinical conversations. They needed clearer positioning and a stronger market presence.

Howbridge helped refine the value proposition, investor communications, website, and stakeholder messaging to support fundraising and market readiness.

Whole Systems developed innovative medical technologies that required extensive physician training, adoption support, and product education. The company needed materials capable of accelerating market adoption and improving product understanding.

Howbridge developed medical illustrations, training videos, and educational materials that simplified complex concepts and supported commercialization efforts.

ProterixBio developed innovative protein-based diagnostic technologies and needed a stronger platform to communicate its scientific differentiation to investors, physicians, and industry stakeholders.

Howbridge helped strengthen positioning, messaging, and communications around the company’s intellectual property and market opportunity.

NVasc was founded around innovative ophthalmology technology focused on treating leading causes of blindness through retinal and choroidal revascularization. As the company prepared for fundraising, it needed a market presence capable of supporting investors and stakeholders.

Howbridge developed the brand, digital presence, and communications platform needed to support investor outreach and commercialization efforts.

Linovasc was founded around a patented cardiovascular technology designed to improve outcomes in aortic procedures through a novel toroidal balloon catheter platform. With the science established and intellectual property secured, the company needed a compelling business case to support fundraising, clinical validation, and future commercialization.

Howbridge helped develop the value proposition, investor narrative, market strategy, and communications platform needed to secure pre-seed funding, engage leading vascular surgeons, and advance the company toward animal and human trials.

Inaya Therapeutics was preparing to emerge from stealth mode and needed a compelling market presence capable of supporting fundraising and stakeholder engagement.

Howbridge developed the company’s brand identity, messaging, website, and communications platform to help leadership communicate its vision and opportunity.

Based in Japan, Asahi Medical Technologies was seeking to expand its presence and market share in the United States.

Howbridge developed the brand platform, messaging architecture, and market-facing materials needed to strengthen positioning, increase awareness, and support continued U.S. growth.

AssayQuant was preparing to enter the market with innovative scientific technology but lacked the positioning and communications needed to tell its story effectively.

Howbridge developed the brand strategy, value proposition, visual identity, and digital presence necessary to support growth and investor engagement.

Alacrity Medical Systems helps early-stage medtech companies turn promising device and diagnostic concepts into commercially viable products.

They needed sharper positioning and commercialization support to communicate their value to founders, investors, and venture groups. Howbridge helped clarify their value proposition, strengthen market positioning, and support commercialization and go-to-market strategy.

Akarna Therapeutics was developing a potentially best-in-class treatment for NASH, one of the fastest-growing unmet needs in healthcare. As the company prepared to announce a major financing event, leadership needed a complete market presence in a matter of weeks.

Howbridge rapidly developed the company’s brand, website, messaging, and launch communications platform to support investors and media outreach.

Women & Infants’ Hospital was focused on growing its reproductive medicine and IVF practice while strengthening connections with patients and referring physicians.

Howbridge helped develop growth-oriented communications, physician positioning, and patient engagement initiatives that elevated awareness of the program’s expertise and supported continued growth.

Kedalion Therapeutics developed AcuStream™, an innovative ocular delivery platform designed to improve dosing precision and patient experience. They needed a clearer commercialization story for investors and strategic partners.

Howbridge helped position the technology, clarify the market opportunity, and build investor and stakeholder communications.

Justice Resource Institute supported Rise On’s mission to expand access to care for underserved communities.

Howbridge helped develop strategy, branding, technology, and outreach for a more accessible care model.

Tufts Medical Center recruited Dr. John Buster and Dr. Sandra Carson to revitalize its reproductive medicine program in one of the country’s most competitive healthcare markets.

Howbridge helped build the department’s brand, website, advertising, patient communications, and physician positioning.

PyrAmes was advancing a non-invasive, wireless blood pressure monitoring platform and needed a clear story for investors, healthcare providers, and commercialization partners.

Howbridge helped refine the value proposition, develop market messaging, and create use case scenarios that demonstrated the platform’s clinical and commercial potential, supporting fundraising and market readiness.

Previvo Genetics was built around breakthrough reproductive medicine technology and needed to move from scientific concept to commercialization.

Howbridge embedded with leadership to support formation, positioning, commercialization strategy, investor communications, patent support, and market readiness.

CadenceOTC set out to make essential women’s health products more accessible by rethinking traditional healthcare distribution models. To support fundraising, clinical studies, consumer adoption, and commercialization, the company needed a clear brand and communications platform.

Howbridge helped develop the market positioning, investor materials, digital assets, clinical trial packaging and participant communications, and product communications that transformed an early-stage concept into a market-ready brand.

InCarda Therapeutics was advancing an inhaled cardiovascular therapy platform and needed to communicate complex innovation to investors, physicians, clinical trial participants, and regulatory stakeholders.

Howbridge helped strengthen brand positioning, investor communications, product packaging, and digital experiences that supported engagement across multiple stakeholder groups.